XML 285 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Total
Share Capital
Share premium
Treasury Shares
Merger reserve
Translation reserve
Other reserve
Retained earnings/ (accumulated deficit)
Total parent equity
Non-controlling interests
Beginning balance number of shares outstanding (in shares) at Dec. 31, 2019   285,370,619                
Equity at beginning of period at Dec. 31, 2019 $ 650,398 $ 5,408 $ 287,962   $ 138,506 $ 0 $ (18,282) $ 254,444 $ 668,037 $ (17,639)
Net income/(loss) 4,568             5,985 5,985 (1,417)
Other comprehensive income/(loss), net 469         469     469  
Total comprehensive income/(loss) for the year 5,037         469   5,985 6,454 (1,417)
Exercise of share-based awards (in shares)   514,406                
Exercise of share-based awards 1,036 $ 9 1,016           1,025 11
Revaluation of deferred tax assets related to share-based awards (684)           (684)   (684)  
Equity settled share-based awards 10,627           7,805   7,805 2,822
Settlement of restricted stock units (12,888)           (12,888)   (12,888)  
Partial settlement of share based liability awards and settlement of equity based RSUs 0                  
Other 13           0 0 0 13
Ending balance number of shares outstanding (in shares) at Dec. 31, 2020   285,885,025                
Equity at end of period at Dec. 31, 2020 653,539 $ 5,417 288,978   138,506 469 (24,050) 260,429 669,748 (16,209)
Net income/(loss) (62,709)             (60,558) (60,558) (2,151)
Other comprehensive income/(loss), net 0                  
Total comprehensive income/(loss) for the year (62,709)         0   (60,558) (60,558) (2,151)
Exercise of share-based awards (in shares)   1,911,560                
Exercise of share-based awards 352 $ 27 326           352 0
Revaluation of deferred tax assets related to share-based awards 615           615   615  
Equity settled share-based awards 13,361           7,109   7,109 6,252
Settlement of restricted stock units (10,749)           (10,749)   (10,749)  
Reclassification of equity settled awards to liability awards (6,773)           (6,773)   (6,773)  
Vesting of share-based awards and net share exercise (2,582)           (2,582)   (2,582)  
Acquisition of subsidiary non-controlling interest (968)           (9,636)   (9,636) 8,668
Partial settlement of share based liability awards and settlement of equity based RSUs 0                  
NCI exercise of share options in subsidiaries 66           5,988   5,988 (5,922)
Other (6)                 (6)
Ending balance number of shares outstanding (in shares) at Dec. 31, 2021   287,796,585                
Equity at end of period at Dec. 31, 2021 584,147 $ 5,444 289,303   138,506 469 (40,077) 199,871 593,515 (9,368)
Net income/(loss) (37,065)             (50,354) (50,354) 13,290
Other comprehensive income/(loss), net (379)         (379)     (379)  
Total comprehensive income/(loss) for the year (37,444)         (379)   (50,354) (50,733) 13,290
Deconsolidation of subsidiary 11,904                 11,904
Exercise of share-based awards (in shares)   577,022                
Exercise of share-based awards 332 $ 11 321           332  
Revaluation of deferred tax assets related to share-based awards 45           45   45  
Purchase of Treasury stock (in shares)       (10,595,347)            
Purchase of Treasury stock (26,492)     $ (26,492)         (26,492)  
Equity settled share-based awards 13,567           8,856   8,856 4,711
Partial settlement of share based liability awards and settlement of equity based RSUs (in shares)   788,046                
Partial settlement of share based liability awards and settlement of equity based RSUs 1,528           1,528   1,528  
NCI exercise of share options in subsidiaries 7           15,171   15,171 (15,164)
Other (4)                 (4)
Ending balance number of shares outstanding (in shares) at Dec. 31, 2022   289,161,653   (10,595,347)            
Equity at end of period at Dec. 31, 2022 $ 547,589 $ 5,455 $ 289,624 $ (26,492) $ 138,506 $ 89 $ (14,478) $ 149,516 $ 542,220 $ 5,369